ODAC

Melasma: Treatment Pearls from the Expert

By May 6, 2020April 12th, 2023No Comments

Dermatology News

Video Pearls

E. Victor Ross, MD, is a dermatologist specializing in laser surgery of the skin. He uses a broad array of technologies to reduce red and brown skin lesions, wrinkles and unwanted hair, improve spider veins of the legs and improve the appearance of scars, including acne scars.

Learn More

Melasma: Treatment Pearls from the Expert

featuring Dr. Vic Ross

Journal of Drugs in Dermatology partners Next Steps in Derm and ODAC Dermatology Aesthetic and Surgical Conference interviewed Dr. Vic Ross, Director of the Scripps Clinic Laser and Cosmetic Dermatology Center in San Diego on his approach and the various interventions he uses for the treatment of Melasma.

More On Melasma

Melasma is a commonly condition that mostly affects women with Fitzpatrick skin types III-VI with prominent brown pigmentation with or without an underlying erythema. Treating Melasma is challenging, due to its chronic nature.

Explore Melasma Articles

ODAC Orlando Dermatology, Aesthetic & Surgical Conference

ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century. Founded in 2003 by dermatology pioneer, Dr. Perry Robins, the ODAC Dermatology Conference provides nearly 700 dermatologists, residents, nurse practitioners and physician assistants with important annual updates and fresh practical pearls in the field of medical, cosmetic and surgical dermatology in a highly interactive format.

Reasons to Attend ODAC 2021

  • Discuss the next generation of diagnostic approaches and evidence-based dermatology treatments
  • Observe cutting-edge procedures and techniques with live demonstrations of novel products and emerging technologies
  • Review clinical trial results and discuss case-studies in both large and small group settings
  • Cultivate relationships with colleagues and leaders actively shaping the future of dermatology
  • Earn CME –  up to 31 AMA PRA Category 1 Credits™
Register for ODAC 2021 Now

You May Also Like

Journal of Drugs in Dermatology JDD Article About Hypochlorous Acid for a Persistent Filler Nodule: A Case Report

Hypochlorous Acid for a Persistent Filler Nodule: A Case Report

| Case Reports, Featured Articles, Latest News, Medical Derm, The Latest | No Comments
Biofilms, Hard Nodules, and the Surprising Power of Hypochlorous Acid Most hyaluronic acid lumps after filler settle on their own, but a rare “delayed-onset” nodule can spell trouble—especially when it…
Journal of Drugs in Dermatology JDD Interview with Dr. Christopher Bunick: An In-Depth Interview Focusing on Atopic Dermatitis and the LEVEL UP Period 2 Data

JDD Interview with Dr. Christopher Bunick: An In-Depth Interview Focusing on Atopic Dermatitis and the LEVEL UP Period 2 Data

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Switching from Dupilumab to Upadacitinib: Practice-Informing Evidence from LEVEL UP SWITCH This exclusive video interview with Dr. Christopher Bunick unveils the practice-changing insights of the LEVEL UP SWITCH study, designed…
Journal of Drugs in Dermatology JDD Article About The Impact of an AGE-Inhibiting Moisturizer on Procedure Effectiveness

The Impact of an AGE-Inhibiting Moisturizer on Procedure Effectiveness

| Featured Articles, Latest News, Skincare, The Latest | No Comments
Harness the Power of AGE Inhibition for Superior Post-Resurfacing Results A breakthrough split-face study shows that a targeted AGE-inhibitory moisturizer dramatically elevates post-resurfacing skincare outcomes for all skin tones. After…

Leave a Reply